Table 1.
Composition of the different mTHPC-DCL formulations.
| Formulation | CD | CD (mM) | mTHPC (mM) | Lipid (mM) |
|---|---|---|---|---|
| Empty liposomes | - | - | - | 26 |
| DCLs with Hp-β-CD 1 | ||||
| HDCL 1 | Hp-β-CD | 200 | 5 | 26 |
| HDCL 2 | 1.7 | |||
| HDCL 3 | 0.5 | |||
| DCLs with Me-β-CD 2 | ||||
| MDCL 1 | Me-β-CD | 20 | 5 | 26 |
| MDCL 2 | 1.7 | |||
| MDCL 3 | 0.5 | |||
| DCLs with TM-β-CD 3 | ||||
| TDCL 1 | TM-β-CD | 10 | 5 | 26 |
| TDCL 2 | 1.7 | |||
| TDCL 3 | 0.5 |
1 Lipid vesicles with mTHPC/Hp-β-CD complexes encapsulated into the inner core. 2 Lipid vesicles with mTHPC/Me-β-CD complexes encapsulated into the inner core. 3 Lipid vesicles with mTHPC/TM-β-CD complexes encapsulated into the inner core.